Skip to content

ARDAL PHARMA

Active Risk: not assessed
Private limited companyfounded 201214 yrs activeFirmin Lecharlierlaan 134, 1090 Jette, BelgiumKBO/BCE: BE 0843.540.209

ARDAL PHARMA has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €789k and a net result of €60k. Equity is growing by ~9.7% per year across the filed fiscal years. Its solvency ranks better than 59% of 31662 sector peers (fiscal year 2025). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit advice for your own amount and term

Signals

Three signals. The signal on the left, the evidence on the right.
neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
18 d late
2024
25 d late
2023
33 d early
2022
29 d early
2021
19 d early
2020
4 d early
2019
10 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€789k▲ 8.2%
2024 · €729k
2018: €367k 2019: €447k 2020: €504k 2021: €563k 2022: €618k 2023: €671k 2024: €729k
2018 → 2025
Total assets
€1.22M▼ 1.6%
2024 · €1.24M
2018: €1.25M 2019: €1.28M 2020: €1.26M 2021: €1.26M 2022: €1.25M 2023: €1.24M 2024: €1.24M
2018 → 2025
Net result
€60k▲ 2.4%
2024 · €58k
2018: €60k 2019: €90k 2020: €57k 2021: €59k 2022: €56k 2023: €53k 2024: €58k
2018 → 2025
Working capital
€-89k▼ 21.1%
2024 · €-74k
2018: €-42k 2019: €-25k 2020: €-30k 2021: €-36k 2022: €-48k 2023: €-63k 2024: €-74k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€563k-€618k▲ 9.9%€671k▲ 8.5%€729k▲ 8.7%€789k▲ 8.2%
Operating result€88k-€83k▼ 4.8%€79k▼ 5.2%€80k▲ 1.7%€82k▲ 1.5%
Net result€59k-€56k▼ 5.3%€53k▼ 5.3%€58k▲ 10.3%€60k▲ 2.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€25k€50k€75k€100kOperating result 2021: €88k€88kNet result 2021: €59k€59kOperating result 2022: €83k€83kNet result 2022: €56k€56kOperating result 2023: €79k€79kNet result 2023: €53k€53kOperating result 2024: €80k€80kNet result 2024: €58k€58kOperating result 2025: €82k€82kNet result 2025: €60k€60k20212022202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 2% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.22M
Fixed assets €1.20M▲ 0.1%
Current assets €15k▼ 58.6%
Equity and liabilities €1.22M
Equity €789k▲ 8.2%
Debt €429k▼ 15.6%
The debt ratio falls from 41.1% to 35.2%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
Solvency
64.8%
2024 · 58.9%
ROE
7.6%
2024 · 8.0%
ROA
4.9%
2024 · 4.7%
Debt
€429k
2024 · €509k
Debt ≤ 1 year
€104k
2024 · €109k
Debt > 1 year
€325k
2024 · €399k
Income taxes
€16k
2024 · €15k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.24M€1.22M
Fixed assets21/28€1.20M€1.20M
Tangible fixed assets22/27€2k€3k
Plant, machinery and equipment23€1k€902
Furniture and vehicles24€1k€3k
Financial fixed assets28€1.20M€1.20M=
Current assets29/58€36k€15k
Amounts receivable within one year40/41€26k€14k
Trade receivables40-€14k
Other amounts receivable41€26k€38
Cash at bank and in hand54/58€9k-
Deferred charges and accrued income490/1€614€686
Equity and liabilities
Total equity and liabilities10/49€1.24M€1.22M
Equity10/15€729k€789k
Contributions10/11€19k€19k=
Reserves13€3k€3k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Tax-exempt reserves132€772€772=
Profit (loss) carried forward14€708k€768k
Amounts payable17/49€509k€429k
Amounts payable after more than one year17€399k€325k
Financial debts170/4€399k€325k
Amounts payable within one year42/48€109k€104k
Current portion of amounts payable after more than one year42€82k€85k
Financial debts43€13€3k
Credit institutions430/8€13€3k
Trade debts44€956€2k
Suppliers440/4€956€2k
Advances received on contracts in progress46€18k-
Taxes, remuneration and social security45€556€6k
Taxes450/3€556€1k
Remuneration and social security454/9-€4k
Other amounts payable47/48€8k€8k
Accrued charges and deferred income492/3€540€323
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€996
Other operating charges640/8€1k€1k
Gross operating margin9900€84k€84k
Operating profit (loss)9901€80k€82k
Financial income75/76B€608€13
Recurring financial income75€608€13
Financial charges65/66B€8k€6k
Recurring financial charges65€8k€6k
Profit (loss) for the period before taxes9903€73k€75k
Income taxes67/77€15k€16k
Profit (loss) for the period9904€58k€60k
Profit (loss) for the period to be appropriated9905€58k€60k
Appropriation of the result
Profit (loss) to be appropriated9906€708k€768k
Profit (loss) brought forward from the previous period14P€650k€708k

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
18-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 18 days late
2025
25-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 25 days late
2024
28-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Weakest financial yearnet €53k ▼5.3%
Net result drops to €53k, the lowest in the series; recovery starts the following year.
02-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
12-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
27-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Equity above €500kEq €504k ▲12.8%
3 profitable years in a row build equity to €504k.
10-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 10 days late
2019
31-12
Financial Highest result since 2018net €90k ▲49.2%
Operating result €119k, net result €90k, both a record.
08-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 8 days late
2018
25-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
31-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jette · 1 establishment unit since 2012
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Firmin Lecharlierlaan 1341090 Jette
Ground area
134 m²
Building footprint
95 m²
Volume, LiDAR
787 m³
Parcel 21464D0077/00P005, Brussels · tallest building 11.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Firmin Lecharlierlaan 134, 1090 Jette
Retail sale of pharmaceutical products
since 20122.207.637.153
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21464D0077/00P005 Brussels 134 m² 1 · 95 m² 11.5 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 82,569 companies in sector 70200 we hold annual accounts for 52,573. 30,377 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded09-02-2012
Fiscal year end31-12
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
47730Retail sale of pharmaceutical products
64200Holdings
64210Activities of holding companies
68110Buying and selling of own real estate
68201Renting and operating of own or leased residential real estate, excluding social housing
68203Renting and operating of own or leased non-residential real estate, excluding land
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.